Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4F4L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,126
Award facts
- Contract value 100% obligated
- $28,125.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 22, 2026, the Defense Logistics Agency awarded a delivery order valued at approximately $28.1K to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and has an ultimate completion date of January 23, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order represents a child contract under the parent entity Cencora, Inc., which does business as AmerisourceBergen and serves as a critical pharmaceutical distributor for federal healthcare systems.
This award is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999.999 million through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications and brand-name and generic drugs, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4F4L?
SPE2DR26F4F4L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F4F4L worth?
The government has obligated $28,126 on SPE2DR26F4F4L.
Is contract SPE2DR26F4F4L an order under another contract?
Yes. SPE2DR26F4F4L is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F4L competed?
The extent of competition for SPE2DR26F4F4L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award